This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Orimabs Ltd.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Weihong Wen: Innovator in Anti-PSMA Antibodies
Introduction: Weihong Wen, an accomplished inventor based in Xi'an, China, has made significant contributions to the field of medical research through his innovative endeavors. With a focus on antibody-related compositions, Wen's work holds promise for advancements in therapeutic applications.
Latest Patents: Weihong Wen is the inventor of a notable patent titled "Anti-PSMA antibodies and use thereof." This invention pertains to compositions and methods utilizing antibodies or antibody fragments that specifically bind to Prostate-Specific Membrane Antigen (PSMA). Such advancements can pave the way for targeted therapies in oncology, particularly in the treatment of prostate cancer.
Career Highlights: Currently, Weihong Wen is associated with Orimabs Ltd., where he applies his expertise in immunology and biotechnology. His dedication and innovative spirit have resulted in a significant patent that showcases his ability to contribute to the scientific community.
Collaborations: Throughout his career, Wen has worked alongside talented colleagues such as Aizhi Zhao and Yueheng Han. Collaborations with these individuals reflect a commitment to advancing research and innovation in the biotech field.
Conclusion: Weihong Wen stands out as a distinguished inventor whose work on anti-PSMA antibodies exemplifies the intersection of innovation and medicine. As he continues to develop his research at Orimabs Ltd., it is anticipated that his contributions will have a lasting impact on the treatment of prostate cancer and beyond.